Former President Donald Trump stated he was unaware of a major investment by an Abu Dhabi royal into World Liberty Financial, a crypto platform he co-founded. The deal, struck just before his inauguration, has reignited debates over foreign influence and the blurring lines between presidential family business and public office.
A new intrinsic value analysis of Moonpig Group PLC suggests the online greeting card retailer's stock may be trading at a significant discount to its fair value, based on projected future cash flows.
Emerging markets investor Gemcorp spins off a new operating platform, Imbono, to bridge the chronic gap between project financing and completion in Africa's energy, water, logistics, and food security sectors.
After a sharp recent pullback, Palantir Technologies' lofty valuation is under the microscope. While its long-term growth narrative remains compelling, traditional metrics suggest the stock may be pricing in near-perfect execution. We examine the numbers behind the debate.
Vaxcyte's shares have surged over 23% in the past month, sparking debate among investors. While a discounted cash flow model suggests significant upside, traditional metrics paint a more cautious picture. We examine the numbers and the narratives driving this biotech stock.
United Natural Foods (UNFI) shares have staged a notable rebound, climbing nearly 30% over the past year. Yet, a closer look at valuation metrics suggests the stock may still be trading at a significant discount. We examine the cash flow and market positioning behind the numbers.
Elon Musk's consolidation of SpaceX and xAI into a single tech giant brings renewed scrutiny to its substantial bitcoin treasury, raising questions about accounting, volatility, and investor strategy as the company eyes a public listing.
ING Deutschland now allows its retail banking customers to invest in Bitcoin, Ethereum, and Solana through regulated, bank-integrated Exchange-Traded Notes, marking a significant step in traditional finance's embrace of digital assets.
Gilead Sciences reports compelling Phase 3 data for its Trodelvy immunotherapy combined with Merck's Keytruda in frontline metastatic triple-negative breast cancer, marking a significant stride in its strategic pivot to expand beyond virology. The company also bolsters its pipeline through a new partnership with Repare Therapeutics.
Genuine Parts Company (NYSE: GPC) shares have delivered impressive 25.8% returns over the past year, outpacing broader market indices. As the stock hovers around $141, investors are divided: is this automotive and industrial parts distributor still a bargain, or has the rally priced in all future gains? A deep dive into valuation metrics reveals a complex picture.
The Biden administration's 'Project Vault' initiative aims to reduce American dependence on Chinese rare earths, creating a potential windfall for domestic, integrated suppliers. USA Rare Earth stands at the intersection of major policy pushes and federal funding.
Former President Bill Clinton and former Secretary of State Hillary Clinton have agreed to appear before the House Oversight Committee, averting a contempt vote after weeks of tense negotiations and political pressure surrounding the Jeffrey Epstein investigation.
As private AI leaders like Anthropic project staggering revenue growth, the spotlight turns to the public-market hardware titans whose chips form the backbone of this expansion. Nvidia and Broadcom are positioned as critical, long-term beneficiaries.
Global data center giant Digital Realty Trust has finalized a deal to acquire the TelcoHub 1 facility in Cyberjaya, marking its formal entry into the Malaysian market and signaling a major expansion of its Southeast Asian footprint.
Packaging Corporation of America's shares have nearly doubled over five years, but a deep dive reveals a split picture: one model screams bargain, while another suggests caution. Investors are left weighing robust historical performance against conflicting signals on current value.
Alliance Resource Partners (ARLP) is attracting renewed investor scrutiny as its share price shows divergent short and long-term trends. While a strong three-year performance contrasts with recent stagnation, analysts debate whether the stock's current discount represents a genuine opportunity or reflects deeper sectoral headwinds.
The Justice Department has removed thousands of documents from its website after a major privacy breach exposed the identities of Jeffrey Epstein's victims. The error, blamed on 'technical or human' failure, has sparked outrage among survivors and raised fresh questions about the transparency of the ongoing investigation.
A Minnesota school district closed its doors Monday following bomb threats, a day after a 5-year-old student and his father were released from immigration detention—an incident that has drawn national scrutiny and raised questions about the family's safety.
Vaxcyte's shares have surged over 38% in three months, reigniting debate on whether the clinical-stage biotech is undervalued or if investors are overlooking significant risks in its unproven pipeline.
A school bus carrying 30-40 elementary students veered off a Sacramento roadway into a creek Monday morning. While all children were safely evacuated without injury, preliminary reports suggest the driver may have fallen asleep at the wheel, sparking an investigation and renewed safety discussions.
